Department of Pediatrics, Northwestern University Feinberg School of Medicine, Center for Autonomic Medicine in Pediatrics, Children's Memorial Hospital, 2300 Children's Plaza, Box 165, Chicago, IL 60614, USA.
Pediatrics. 2011 Sep;128(3):e711-5. doi: 10.1542/peds.2011-0155. Epub 2011 Aug 1.
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) falls within a group of pediatric disorders with both respiratory control and autonomic nervous system dysregulation. Children with ROHHAD typically present after 1.5 years of age with rapid weight gain as the initial sign. Subsequently, they develop alveolar hypoventilation, autonomic nervous system dysregulation, and, if untreated, cardiorespiratory arrest. To our knowledge, this is the first report of discordant presentation of ROHHAD in monozygotic twins. Twin girls, born at term, had concordant growth and development until 8 years of age. From 8 to 12 years of age, the affected twin developed features characteristic of ROHHAD including obesity, alveolar hypoventilation, scoliosis, hypothalamic dysfunction (central diabetes insipidus, hypothyroidism, premature pubarche, and growth hormone deficiency), right paraspinal/thoracic ganglioneuroblastoma, seizures, and autonomic dysregulation including altered pain perception, large and sluggishly reactive pupils, hypothermia, and profound bradycardia that required a cardiac pacemaker. Results of genetic testing for PHOX2B (congenital central hypoventilation syndrome disease-defining gene) mutations were negative. With early recognition and conservative management, the affected twin had excellent neurocognitive outcome that matched that of the unaffected twin. The unaffected twin demonstrated rapid weight gain later in age but not development of signs/symptoms consistent with ROHHAD. This discordant twin pair demonstrates key features of ROHHAD including the importance of early recognition (especially hypoventilation), complexity of signs/symptoms and clinical course, and importance of initiating comprehensive, multispecialty care. These cases confound the hypothesis of a monogenic etiology for ROHHAD and indicate alternative etiologies including autoimmune or epigenetic phenomenon or a combination of genetic predisposition and acquired precipitant.
快速进展性肥胖伴下丘脑功能障碍、通气不足和自主神经功能紊乱(ROHHAD)属于一组具有呼吸控制和自主神经系统功能障碍的儿科疾病。患有 ROHHAD 的儿童通常在 1.5 岁后以快速体重增加为初始症状出现。随后,他们会出现肺泡通气不足、自主神经系统功能紊乱,如果不治疗,还会出现心肺骤停。据我们所知,这是首例同卵双胞胎 ROHHAD 表现不一致的报告。这对双胞胎女孩足月出生,在 8 岁之前生长发育一致。从 8 岁到 12 岁,受影响的双胞胎出现了 ROHHAD 的特征性表现,包括肥胖、肺泡通气不足、脊柱侧凸、下丘脑功能障碍(中枢性尿崩症、甲状腺功能减退、性早熟和生长激素缺乏)、右脊柱旁/胸神经节神经母细胞瘤、癫痫发作和自主神经功能紊乱,包括疼痛感知改变、大而反应迟钝的瞳孔、体温过低和严重心动过缓,需要心脏起搏器。PHOX2B(先天性中枢性低通气综合征疾病定义基因)基因突变的遗传检测结果为阴性。通过早期识别和保守治疗,受影响的双胞胎在神经认知方面取得了极佳的结果,与未受影响的双胞胎相匹配。未受影响的双胞胎在年龄较大时表现出快速的体重增加,但没有出现与 ROHHAD 一致的体征/症状。这对不一致的双胞胎展示了 ROHHAD 的关键特征,包括早期识别(尤其是通气不足)的重要性、体征/症状和临床过程的复杂性以及启动全面多学科护理的重要性。这些病例使 ROHHAD 的单基因病因假说变得复杂,并表明存在其他病因,包括自身免疫或表观遗传现象或遗传易感性和获得性诱因的组合。